These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28450284)
1. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids. Kandhi S; Zhang B; Froogh G; Qin J; Alruwaili N; Le Y; Yang YM; Hwang SH; Hammock BD; Wolin MS; Huang A; Sun D Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L350-L359. PubMed ID: 28450284 [TBL] [Abstract][Full Text] [Related]
2. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase. Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250 [TBL] [Abstract][Full Text] [Related]
3. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. Keserü B; Barbosa-Sicard E; Popp R; Fisslthaler B; Dietrich A; Gudermann T; Hammock BD; Falck JR; Weissmann N; Busse R; Fleming I FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458 [TBL] [Abstract][Full Text] [Related]
4. Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs. Kandhi S; Alruwaili N; Wolin MS; Sun D; Huang A Pulm Circ; 2019; 9(4):2045894019895947. PubMed ID: 31908769 [TBL] [Abstract][Full Text] [Related]
5. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide. Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584 [TBL] [Abstract][Full Text] [Related]
6. EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. Kandhi S; Froogh G; Qin J; Luo M; Wolin MS; Huang A; Sun D Am J Hypertens; 2016 May; 29(5):598-604. PubMed ID: 26304959 [TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure. Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863 [TBL] [Abstract][Full Text] [Related]
13. 11,12-EET stimulates the association of BK channel α and β(1) subunits in mitochondria to induce pulmonary vasoconstriction. Loot AE; Moneke I; Keserü B; Oelze M; Syzonenko T; Daiber A; Fleming I PLoS One; 2012; 7(9):e46065. PubMed ID: 23029390 [TBL] [Abstract][Full Text] [Related]
14. Sexually dimorphic phenotype of arteriolar responsiveness to shear stress in soluble epoxide hydrolase-knockout mice. Qin J; Kandhi S; Froogh G; Jiang H; Luo M; Sun D; Huang A Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1860-6. PubMed ID: 26453332 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276 [TBL] [Abstract][Full Text] [Related]
17. Predominant role of vasoconstrictors over dilatators derived from arachidonic acid in hypoxic pulmonary vasoconstriction. Han Y; Yan G; Wang Q; Ma G; Tang C; Gu Y; Li L; Zhao J Mol Med Rep; 2013 Oct; 8(4):1263-71. PubMed ID: 23970347 [TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921 [TBL] [Abstract][Full Text] [Related]
19. Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen. Huang A; Sun D Front Pharmacol; 2018; 9():1222. PubMed ID: 30420806 [TBL] [Abstract][Full Text] [Related]
20. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels. Liu Y; Zhang J; Yu L; Cao F; Rao J; Li J; Jiang C; Falck JR; Jacobs ER; Zhu D Pulm Pharmacol Ther; 2012 Feb; 25(1):69-76. PubMed ID: 22155000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]